Ottawa, Ontario — Friday October 2, 2020
Stage 3 of the Canada Research Continuity Emergency Fund (CRCEF) has now been launched, and the purpose of this email is to describe the internal process by which research leads (principal investigators) who hold and manage research funds at the CHEO Research Institute can apply for to receive funds. The purpose of this funding is ‘to support extraordinary incremental costs associated with maintaining essential research-related commitments during the COVID-19 pandemic, and then ramping-up to full research activities as physical distancing measures are eased and research activities can resume ($125 million).’
Our funding allocation is $315,740.93. Please note that we are able to request additional funds beyond this, if we have the proper justification. Only direct costs of research are eligible. Applicants must justify the need for the funds based on actual costs that have been incurred or costs that will be incurred between March 15 and November 15, 2020. (Please note that in order to meet this eligibility period any new transactions must be incurred by October 21st.)
The guideline document and application form provides you with all the information on how to submit your request. You can access the information on CHEOnet by clicking here. Applications must be received by the CHEO Grants Office ([email protected]) by noon October 19th.
Dr. Jason Berman
Chief Executive Officer and Scientific Director, CHEO Research Institute
Vice President Research, CHEO